Cancer Immunotherapy Market: By Product Type, By Cancer Type and Region Forecast 2019-2030 

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Cancer Immunotherapy Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Oncolytic Viral Therapies & Cancer Vaccines, Monoclonal Antibodies, Immunomodulators), By Cancer Type (Breast, Lung) and Region Forecast 2019-2030 

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Cancer Immunotherapy Market size was valued at US$ 120 billion in 2023. It is expected to reach a value of US$ 304 billion by 2030, growing at a CAGR of 14.2% from 2024-2030. The global market provides a detailed overview of the market and that can be segmented by product type and cancer type. By product type, the market has been segmented into oncolytic viral therapies & cancer vaccines, monoclonal antibodies, and immunomodulators. The oncolytic viral therapies & cancer vaccines segment is likely to be the largest and fastest-growing segment in terms of product type. Based on cancer type, the market is segmented into breast and lung. Among these, the breast segment is expected to have the fastest-growing market during the forecast period.

summary download arrow Download Free Sample

Cancer Immunotherapy Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

14.2%

Largest Market

North America

Fastest Growing Market

Asia-Pacific

Cancer Immunotherapy Market Dynamics

Some of the key factors boosting the market growth include rising spending on healthcare needs, a surge in cancer cases, increasing R&D efforts in the field of cancer immunotherapy, and increasing use of modern cancer therapy alternatives. Moreover, immunotherapy is becoming more popular and has strong growth potential in developing nations.

Cancer Immunotherapy Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 120 billion

Market Size in 2030

US$ 304 billion

Market CAGR

14.2%

By Product Type

  • Oncolytic Viral Therapies & Cancer Vaccines
  • Monoclonal Antibodies
  • Immunomodulators

By Cancer Type

  • Breast
  • Lung

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The cancer immunotherapy market report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and startup's details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The cancer immunotherapy market size was valued at US$ 120 billion in 2023 and is set to reach US$ 5.9 billion by 2030 at a CAGR of 14.2% from 2024-2030

The major players in the global market are Amgen, Inc., Astrazeneca, PLC, Bayer AG, Bristol-Myers Squibb Company, Eli Lily and Company, F. Hoffmann-La Roche, Ltd. (Genentech, Inc.), Pfizer, Inc., Johnson & Johnson (Janssen Global Services, LLC), Merck KGAA and Novartis AG.

Asia Pacific is the fastest-growing region in the market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Cancer Immunotherapy Market Introduction 
2.1.Global Cancer Immunotherapy Market  - Taxonomy
2.2.Global Cancer Immunotherapy Market  - Definitions
2.2.1. By Product Type
2.2.2. By Cancer Type
2.2.3. By Region
3.Global Cancer Immunotherapy Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Cancer Immunotherapy Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Cancer Immunotherapy Market  By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Oncolytic Viral Therapies & Cancer Vaccines
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Monoclonal Antibodies
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Immunomodulators
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Cancer Immunotherapy Market  By Cancer Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Breast
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Lung
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Cancer Immunotherapy Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Cancer Immunotherapy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Oncolytic Viral Therapies & Cancer Vaccines
8.1.2.Monoclonal Antibodies
8.1.3.Immunomodulators
8.2.  Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Breast
8.2.2.Lung
8.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Cancer Immunotherapy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Oncolytic Viral Therapies & Cancer Vaccines
9.1.2.Monoclonal Antibodies
9.1.3.Immunomodulators
9.2.  Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Breast
9.2.2.Lung
9.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Cancer Immunotherapy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Oncolytic Viral Therapies & Cancer Vaccines
10.1.2.Monoclonal Antibodies
10.1.3.Immunomodulators
10.2.  Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Breast
10.2.2.Lung
10.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Cancer Immunotherapy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Oncolytic Viral Therapies & Cancer Vaccines
11.1.2.Monoclonal Antibodies
11.1.3.Immunomodulators
11.2.  Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Breast
11.2.2.Lung
11.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Cancer Immunotherapy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Oncolytic Viral Therapies & Cancer Vaccines
12.1.2.Monoclonal Antibodies
12.1.3.Immunomodulators
12.2.  Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Breast
12.2.2.Lung
12.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Amgen, Inc
13.2.2.Astrazeneca, PLC
13.2.3.Bayer AG
13.2.4.Bristol-Myers Squibb Company
13.2.5.Eli Lily and Company
13.2.6.Hoffmann-La Roche, Ltd. (Genentech, Inc.)
13.2.7.Pfizer, Inc.
13.2.8.Johnson & Johnson (Janssen Global Services, LLC)
13.2.9.Merck KGAA
13.2.10.Novartis AG
14. Research Methodology 
15. Appendix and Abbreviations 

Key Market Players

  • Amgen, Inc
  • Astrazeneca, PLC
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Eli Lily and Company
  • Hoffmann-La Roche, Ltd. (Genentech, Inc.)
  • Pfizer, Inc.
  • Johnson & Johnson (Janssen Global Services, LLC)
  • Merck KGAA
  • Novartis AG

Related Industry Reports

Global Ovarian Cancer Treatment Market

Global Cancer Monoclonal Antibodies Market

Global Cancer Biomarker Testing Market

Global Anaphylaxis Treatment Market